1 Department of Medicine and Surgery, University of Parma, Italy.
2 General and Specialistic Surgery Department, Azienda Ospedaliero Universitaria di Parma, Italy.
Eur J Prev Cardiol. 2018 Jun;25(1_suppl):32-41. doi: 10.1177/2047487318759121.
Background Gender-related biases in outcomes after thoracic aortic surgery are an important factor to consider in the prevention of potential complications related to aortic diseases and in the analysis of surgical results. Methods The aim of this study is to provide an up-to-date review of gender-related differences in the epidemiology, specific risk factors, outcome, and screening and prevention programmes in aortic aneurysms. Results Female patients affected by aortic disease still have worse outcomes and higher early and late mortality than men. It is difficult to plan new specific strategies to improve outcomes in women undergoing major aortic surgery, given that the true explanations for their poorer outcomes are as yet not clearly identified. Some authors recommend further investigation of hormonal or molecular explanations for the sex differences in aortic disease. Others stress the need for quality improvement projects to quantify the preoperative risk in high-risk populations using non-invasive tests such as cardiopulmonary exercise testing. Conclusions The treatment of patients classified as high risk could thus be optimised before surgery becomes necessary by means of numerous strategies, such as the administration of high-dose statin therapy, antiplatelet treatment, optimal control of hypertension, lifestyle improvement with smoking cessation, weight loss and careful control of diabetes. Future efforts are needed to understand better the gender differences in the diagnosis, management and outcome of aortic aneurysm disease, and for appropriate and modern management of female patients.
在胸主动脉手术后的结果中,性别相关的偏见是预防与主动脉疾病相关的潜在并发症和分析手术结果时需要考虑的一个重要因素。
本研究旨在提供关于主动脉瘤的流行病学、特定风险因素、结果以及筛查和预防计划中性别差异的最新综述。
患有主动脉疾病的女性患者的结局仍比男性患者差,且早期和晚期死亡率更高。由于尚未明确确定导致女性患者结局较差的确切原因,因此很难计划新的具体策略来改善接受大主动脉手术的女性患者的结局。一些作者建议进一步研究激素或分子解释主动脉疾病中的性别差异。其他人强调需要使用心肺运动测试等非侵入性检查来量化高危人群的术前风险,以开展质量改进项目。
通过多种策略,例如高剂量他汀类药物治疗、抗血小板治疗、高血压的最佳控制、戒烟、减肥和糖尿病的精心控制,可以在手术前优化被归类为高危的患者的治疗。需要进一步努力来更好地理解主动脉瘤疾病的诊断、管理和结果中的性别差异,并为女性患者提供适当和现代的管理。